[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
Creutzig
A
A
Abteilung Angiologie, Zentrum Innere Medizin und Dermatologie, Medizinischen Hochschule, Hannover.
D003327:Coronary Disease / Q000139:chemically induced*; D004087:Dihydroergotamine / Q000009:adverse effects; D004878:Ergotamine / Q000009:adverse effects*; D005355:Fibrosis; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000473:pathology; D006351:Heart Valves / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced
D004087:Dihydroergotamine; D004878:Ergotamine
Ergotamin-induzierte Herzklappenfibrosierung und Koronarmikroangiopathie?